Principal Technologies, Inc. (TSE:PTEC) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Principal Technologies Inc. announces a significant acquisition of a 70.7% controlling interest in Swiss medical developer Syndermix AG, valued at $44 million, to expand its portfolio with innovative medical technologies. This strategic move is expected to transform Principal’s offerings, incorporating Syndermix’s cutting-edge assets like BioEleSonic, Noxogen Therapeutics, and TheraLect. ESGTI AG will become a major shareholder following this acquisition.
For further insights into TSE:PTEC stock, check out TipRanks’ Stock Analysis page.